Effect of metformin on doxorubicin-induced cardiotoxicity in experiment

The article provides an overview of the currently known descriptions of the mechanisms and toxic effects of two drugs: doxorubicin, a first-line drug for the treatment of cancer, and the mechanisms of action of Metformin, a drug widely used for the treatment of diabetes mellitus 2. The review made with the usage of NCBI, PubMed and OxfordAcademic presents the analysis of published data on the protective effect of Metformin in its combined use with doxorubicin in an experiment in an attempt to reduce the manifestations of doxorubicin-induced cardiotoxicity. © 2021 Izdatel'stvo Meditsina. All rights reserved.

Авторы
Ionov S.V. 1 , Orlova V.S. 1 , Kulbachevskaya N.Yu.2
Журнал
Издательство
Izdatel'stvo Meditsina
Номер выпуска
1
Язык
Русский
Страницы
35-39
Статус
Опубликовано
Том
67
Год
2021
Организации
  • 1 Peoples' Friendship University of Russia, Moscow, Russian Federation
  • 2 N. N. Blokhin National Medical Research Center of Oncology, Moscow, Russian Federation
Ключевые слова
Cardiotoxicity; Doxorubicin; Metformin; Oxidative stress; Reactive oxygen species
Цитировать
Поделиться

Другие записи

Piradov M.A., Suponeva N.A., Ryabinkina Yu.V., Gnedovskaya E.V., Ilyina K.A., Yusupova D.G., Zimin A.A., Legostaeva L.A., Yazeva E.G., Bakulin I.S., Zaitsev A.B., Polekhina N.V., Bundhun P., Ramchandani N.M., Samorukov V.Y., Domashenko M.A.
Sklifosovsky Journal Emergency Medical Care. Sklifosovsky Research Institute for Emergency Medicine. Том 10. 2021. С. 91-99
Kosorukova A.A., Zubkova U.V.
Вестник Российского университета дружбы народов. Серия: Философия. Федеральное государственное автономное образовательное учреждение высшего образования Российский университет дружбы народов (РУДН). Том 25. 2021. С. 59-71